EMV
EMVISION MEDICAL DEVICES LTD
$1.70
▼ -2.30%
Market cap
$158M
Turnover
$41,879
Last price
$1.70
Day change
-2.30%
Announcements
11
Range, past year
Open 1.935 · Low 1.470 · Now 1.700 · High 2.430
Open EMV in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
EMV momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
33/100
Wyckoff phase
Downtrend1d
Trend stage
Breakdown
1 Day
-2.3%
1 Week
+1.2%
1 Month
+1.8%
1 Year
-12.4%
RSI
47
Avg daily range
4.0%
EMVISION MEDICAL DEVICES LTD scores 33 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Breakdown.
On the Wyckoff cycle it sits in Downtrend, where it has been for 1 trading day. The weekly timeframe reads Uptrend, which does not yet agree with the daily view.
Against the wider market it is currently outperforming and the institutional accumulation signal reads low.
Points to watch
- Thin liquidity
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highsEMV announcements
Recent price-sensitive releases.
- 2026-09-28 $4.3m Non-Dilutive R&D Tax Rebate Received Progress Report | Company Administration - Other
- 2026-09-16 First Responder Successfully Trialled with MSU Progress Report
- 2026-09-03 emu Regional Benefits Study Advancing Progress Report
- 2026-08-31 emu Pivotal Trial Recruitment Surpasses 200 Patients Progress Report
- 2026-08-24 Appendix 4E & Annual Report to 30 June 2026 Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-07-15 Quarterly Activities/Appendix 4C Cash Flow Report
- 2026-05-27 Aeromedical Study De-Risks Rural & Remote Stroke Use Cases
More Health Care stocks
Most traded in the same sector.